Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance

American Journal of Clinical Nutrition

Volumn 96, Issue 1, 2012, Pages 196-207

  Johansson, Lovisa E ^a   Danielsson, Anders P H ^a   Parikh, Hemang ^a,c   Klintenberg, Maria ^a   Norstrom̈, Fredrik ^b   Groop, Leif ^a   Ridderstral̊e, Martin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CHOLESTEROL ESTER TRANSFER PROTEIN; GELATINASE B; RNA;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; ARTICLE; CELL DEATH INDUCING DFFA(DNA FRAGMENTATION FACTOR ALPHA)LIKE EFFECTOR A GENE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LOW CALORY DIET; MALE; NUCLEOTIDE SEQUENCE; OBESITY; PNPLA3 GENE; REAL TIME POLYMERASE CHAIN REACTION; STEAROYL COENZYME A DESATURASE GENE; TENOMODULIN GENE; WEIGHT REDUCTION;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; BIOPSY; BODY MASS INDEX; CHOLESTEROL ESTER TRANSFER PROTEINS; DIET, REDUCING; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECURRENCE; RNA, MESSENGER; SUBCUTANEOUS FAT, ABDOMINAL; WEIGHT LOSS;

EID: 84863562798     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.020578     Document Type: Article

References (55)

1. Kaplan LM. Body weight regulation and obesity. J Gastrointest Surg 2003;7:443-51. (Pubitemid 36877181)
2. Márquez-Quiñones A, Mutch DM, Debard C, Wang P, Combes M, Roussel B, Holst C, Martinez JA, Handjieva-Darlenska T, Kalouskova P, et al. Adipose tissue transcriptome reflects variations between subjects with continued weight loss and subjects regaining weight 6 mo after caloric restriction independent of energy intake. Am J Clin Nutr 2010;92:975-84.
3. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-6. (Pubitemid 46024990)
4. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007;30:1562-6. (Pubitemid 46871171)
5. Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med 2003;138:383-9. (Pubitemid 36262648)
6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl JMed 2002;346:393-403. (Pubitemid 34437694)
7. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003;26:3230-6. (Pubitemid 37466880)
8. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222: 339-50, discussion 50-2.
9. Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie M-E, Mill J, Pérusse L, Vohl M-C. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr 2010;91:309-20.
10. Capel F, Klimčáková E, Viguerie N, Roussel B, Vítková M, KováčikováM, Polák J, Kováčová Z, Galitzky J, Maoret J-J, et al. Macrophages and adipocytes in human obesity. Diabetes 2009;58:1558-67.
11. Clément K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004;18:1657-69. (Pubitemid 39463705)
12. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, Verdich C, Sorensen TI, Arner P. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 2005;81:1275-85. (Pubitemid 41710227)
13. Kolehmainen M, Salopuro T, Schwab US, Kekalainen J, Kallio P, Laaksonen DE, Pulkkinen L, Lindi VI, Sivenius K, Mager U, et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes (Lond) 2008;32:292-303. (Pubitemid 351271783)
14. Liu H, Zeeberg BR, Qu G, Koru AG, Ferrucci A, Kahn A, Ryan MC, Nuhanovic A, Munson PJ, Reinhold WC, et al. AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics 2007;23:2385-90. (Pubitemid 47423835)
15. Millenaar FF, Okyere J, May ST, van Zanten M, Voesenek LA, Peeters AJ. How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics 2006;7:137.
16. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15.
17. McClintick JN, Edenberg HJ. Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinformatics 2006;7:49.
18. Pawitan Y, Michiels S, Koscielny S, Gusnanto A, Ploner A. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 2005;21:3017-24. (Pubitemid 40916427)
19. Grant GR, Liu J, Stoeckert CJ Jr. A practical false discovery rate approach to identifying patterns of differential expression in microarray data. Bioinformatics 2005;21:2684-90. (Pubitemid 40852315)
20. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005;33:W741-8. (Pubitemid 44530021)
21. Kováčiková M, Sengenes C, Kovacova Z, Siklova-Vitkova M, Klimcakova E, Polak J, Rossmeislova L, Bajzova M, Hejnova J, Hnivkovska Z, et al. Dietary intervention-induced weight loss decreases macrophage content in adipose tissue of obese women. Int J Obes (Lond) 2011;35:91-8.
22. Mutch DM, Pers TH, Temanni MR, Pelloux V, Marquez-Quinones A, Holst C, Martinez JA, Babalis D, van Baak MA, Handjieva-Darlenska T, et al. A distinct adipose tissue gene expression response to caloric restriction predicts 6-mo weight maintenance in obese subjects. Am J Clin Nutr 2011;94:1399-409.
23. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003;278:11888-96. (Pubitemid 36800160)
24. Schram K, Sweeney G. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure. Trends Cardiovasc Med 2008;18:199-205.
25. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516. (Pubitemid 33096184)
26. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002;22:374-9. (Pubitemid 34218741)
27. Saiki A, Olsson M, Jernås M, Gummesson A, McTernan PG, Andersson J, Jacobson P, Sjöholm K, Olsson B, Yamamura S, et al. Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down- regulated during diet-induced weight loss. J Clin Endocrinol Metab 2009; 94:3987-94.
28. Tolppanen A-M, Kolehmainen M, Pulkkinen L, Uusitupa M. Teno-modulin gene and obesity-related phenotypes. Ann Med 2010;42: 265-75.
29. Oshima Y, Sato K, Tashiro F, Miyazaki J, Nishida K, Hiraki Y, Tano Y, Shukunami C. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci 2004;117:2731-44. (Pubitemid 38997256)
30. Oshima Y, Shukunami C, Honda J, Nishida K, Tashiro F, Miyazaki J, Hiraki Y, Tano Y. Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest Ophthalmol Vis Sci 2003;44:1814-23. (Pubitemid 36520267)
31. Tolppanen AM, Pulkkinen L, Kolehmainen M, Schwab U, Lindstrom J, Tuomilehto J, Uusitupa M. Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study. Obesity (Silver Spring) 2007;15:1082-8. (Pubitemid 46932462)
32. Johansson LE, Hoffstedt J, Parikh H, Carlsson E, Wabitsch M, Bondeson A-G, Hedenbro J, Tornqvist H, Groop L, Ridderstråle M. Variation in the adiponutrin gene influences its expression and associates with obesity. Diabetes 2006;55:826-33. (Pubitemid 43343243)
33. Johansson LE, Lindblad U, Larsson CA, Råstam L, Ridderstråle M. Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity. Eur J Endocrinol 2008;159:577-83.
34. Kotronen A, Johansson L, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher R, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009;52:1056-60.
35. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011;7:e1001324.
36. Gummesson A, Jernas M, Svensson PA, Larsson I, Glad CA, Schele E, Gripeteg L, Sjoholm K, Lystig TC, Sjostrom L, et al. Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies. J Clin Endocrinol Metab 2007;92:4759-65. (Pubitemid 350223457)
37. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 2005;12:882-93. (Pubitemid 41170488)
38. Nordström EA, Ryden M, Backlund EC, Dahlman I, Kaaman M, Blomqvist L, Cannon B, Nedergaard J, Arner P. A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 2005; 54:1726-34. (Pubitemid 40770763)
39. Zhou Z, Yon Toh S, Chen Z, Guo K, Ng CP, Ponniah S, Lin SC, Hong W, Li P. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 2003;35:49-56. (Pubitemid 37048595)
40. Dobrzyn P, Ntambi JM, Dobrzyn A. Stearoyl-CoA desaturase: a novel control point of lipid metabolism and insulin sensitivity. Eur J Lipid Sci Technol 2008;110:93-100.
41. Sjögren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia 2008;51:328-35.
42. Mangravite LM, Dawson K, Davis RR, Gregg JP, Krauss RM. Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. Am J Clin Nutr 2007;86:759-67. (Pubitemid 47435845)
43. Popeijus HE, Saris WH, Mensink RP. Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome. Int J Obes (Lond) 2008;32: 1076-82. (Pubitemid 351986202)
44. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, Carlson S, Helgason A, Walters GB, Gunnarsdottir S, et al. Genetics of gene expression and its effect on disease. Nature 2008;452:423-8. (Pubitemid 351450845)
45. Gómez-Ambrosi J, Catalan V, Diez-Caballero A, Martinez-Cruz LA, Gil MJ, Garcia-Foncillas J, Cienfuegos JA, Salvador J, Mato JM, Fruhbeck G. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004;18:215-7.
46. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-7. (Pubitemid 46024993)
47. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005; 48:1776-83. (Pubitemid 41317831)
48. Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ, Bogardus C, Permana PA. Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 2005;48:1784-8. (Pubitemid 41317832)
49. Pietiläinen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keranen H, Suomalainen A, Gotz A, Suortti T, Yki-Jarvinen H, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008;5:e51.
50. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277-86. (Pubitemid 41134253)
51. Keller MP, Attie AD. Physiological insights gained from gene expression analysis in obesity and diabetes. Annu Rev Nutr 2010;30:341-64.
52. Ye D, Lammers B, Zhao Y, Meurs I, Van BTJC, Van EM. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Curr Drug Targets 2011;12:647-60.
53. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011;364:127-35.
54. Toth PP. CETP Inhibition: does the future look promising? Curr Cardiol Rep 2011;13:559-65.
55. Aron-Wisnewsky J, Julia Z, Poitou C, Bouillot J-L, Basdevant A, Chapman MJ, Clement K, Guerin M. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab 2011;96:1151-9.